admin
- businessweekly
- December 4, 2020
- 51 views
16 days of business activism
Our sisters and brothers at Population Services International (PSI) found themselves in a bit of a “pickle” with their 16-days of activism campaign.
- businessweekly
- December 4, 2020
- 71 views
‘Time spent on smartphone has no effect on mental health’
Contrary to popular belief, new research finds time spent on smartphones not linked to mental health problems.
- businessweekly
- December 4, 2020
- 80 views
General Beltings forecasts improved performance
Listed conveyor belts manufacturer, General Beltings Holdings Limited, forecasts improved performance for the full year on the back of a strong order book.
- businessweekly
- December 4, 2020
- 61 views
Investors reflect on Bitcoin’s record run
On Monday, Bitcoin fans were rewarded with a long-yearned-for milestone: a record high for the world’s largest digital asset.
Covid vaccine update: When will others be ready?
James Gallagher A Covid vaccine developed by Pfizer/BioNtech has been approved for use in the UK. But how does it compare with other vaccines under development? Why do we need…
- businessweekly
- December 4, 2020
- 101 views
REITs to unlock liquidity for institutional investors
Institutional investors such as pension funds have long piled into real estate investment as a way to hedge their funds against inflation in the long-term.
More people are getting COVID-19 twice, suggesting immunity wanes quickly in some
Jop de Vrieze In late June, Sanne de Jong developed nausea, shortness of breath, sore muscles, and a runny nose. At first, she thought it might be lingering effects from…
Chronicle Editor
- Chronicle
- December 4, 2020
- 86 views
Food preservation enterprise works wonders for Gokwe family
Patrick Chitumba, Midlands Bureau Chief MRS Sheila Mashamatate from Gokwe South’s Ward 16 is a hypertension and diabetes patient who requires about US$20 to buy medication every month. For years,…
Covid-19 carriers ‘most infectious earlier on’
Smitha Mundasad The research indicates patients had the highest levels of virus early on in their illness and “live” virus, capable of replicating, was found up to nine days after…
COVID-19 vaccine trials in Africa: what’s promising, and what’s problematic
Benjamin Kagina THE CONVERSATION AFRICA – Scientists are working around the clock to develop and test vaccines against SARS-CoV-2, the causative agent of COVID-19. Experts agree that widespread use of…